Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases

Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases

Brain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the t...

Full description

Bibliographic Details
Main Authors: Liyan QU, Rui GENG, Xia SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Brain metastases
Bevacizumab
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05
id doaj-3b7c99408e2741cbb209adbe9507cfcc
record_format Article
spelling doaj-3b7c99408e2741cbb209adbe9507cfcc2020-11-24T23:37:14ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872016-08-0119851551810.3779/j.issn.1009-3419.2016.08.05Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain MetastasesLiyan QU0Rui GENG1Xia SONG2Department of Pulmonary Oncology, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan 030013, ChinaDepartment of Pulmonary Oncology, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan 030013, ChinaDepartment of Pulmonary Oncology, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan 030013, ChinaBrain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the treatment of lung cancer with brain metastases beyond the whole brain radiation therapy, stereotactic radiosurgery and chemotherapy. Recently, more and more studies and trials laid emphasis on the bevacizumab for NSCLC with brain metastases treatment. The key point is the efficacy and safety. In this review, bevacizumab therapy of NSCLC with brain metastases were summarized.http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05Lung neoplasmsBrain metastasesBevacizumab
collection DOAJ
language zho
format Article
sources DOAJ
author Liyan QU
Rui GENG
Xia SONG
spellingShingle Liyan QU
Rui GENG
Xia SONG
Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
Chinese Journal of Lung Cancer
Lung neoplasms
Brain metastases
Bevacizumab
author_facet Liyan QU
Rui GENG
Xia SONG
author_sort Liyan QU
title Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
title_short Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
title_full Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
title_fullStr Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
title_full_unstemmed Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases
title_sort advances in bevacizumab therapy for non-small cell lung cancer 
with brain metastases
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
series Chinese Journal of Lung Cancer
issn 1009-3419
1999-6187
publishDate 2016-08-01
description Brain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the treatment of lung cancer with brain metastases beyond the whole brain radiation therapy, stereotactic radiosurgery and chemotherapy. Recently, more and more studies and trials laid emphasis on the bevacizumab for NSCLC with brain metastases treatment. The key point is the efficacy and safety. In this review, bevacizumab therapy of NSCLC with brain metastases were summarized.
topic Lung neoplasms
Brain metastases
Bevacizumab
url http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05
work_keys_str_mv AT liyanqu advancesinbevacizumabtherapyfornonsmallcelllungcancerwithbrainmetastases
AT ruigeng advancesinbevacizumabtherapyfornonsmallcelllungcancerwithbrainmetastases
AT xiasong advancesinbevacizumabtherapyfornonsmallcelllungcancerwithbrainmetastases
_version_ 1725520811581767680

Similar Items